Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia
医学
家族性高胆固醇血症
内科学
儿科
胆固醇
作者
Janneke W. C. M. Mulder,Tycho R. Tromp,Mutaz Al-Khnifsawi,Dirk Blom,Krysztof Chlebus,Marina Cuchel,Laura D’Erasmo,Antonio Gallo,G. Kees Hovingh,Ngoc‐Thanh Kim,Long Jiang,Frederick J. Raal,Willemijn A.M. Schonck,Handrean Soran,Thanh‐Huong Truong,Eric Boersma,Jeanine E. Roeters van Lennep,Mohammed Alareedh,Rano Alieva,Massimiliano Allevi
出处
期刊:JAMA Cardiology [American Medical Association] 日期:2024-02-14卷期号:9 (4): 313-313被引量:15
Homozygous familial hypercholesterolemia (HoFH) is a rare genetic condition characterized by extremely increased low-density lipoprotein (LDL) cholesterol levels and premature atherosclerotic cardiovascular disease (ASCVD). Heterozygous familial hypercholesterolemia (HeFH) is more common than HoFH, and women with HeFH are diagnosed later and undertreated compared to men; it is unknown whether these sex differences also apply to HoFH.